康臣药业10月27日斥资154万港元回购10万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1 - The company will repurchase 100,000 shares at a total cost of HKD 1.54 million [1] - The buyback is scheduled for October 27, 2025, suggesting a strategic long-term investment approach [1]